Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Indaptus Therapeutics, Inc. (INDP) had Stock-Based Compensation of $0.42M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.23M |
|
-- |
|
-- |
|
$4.46M |
|
$-4.46M |
|
$-0.77M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-5.23M |
|
$-4.46M |
|
$-4.46M |
|
0.57M |
|
0.57M |
|
$-9.09 |
|
$-9.09 |
|
| Balance Sheet Financials | |
$6.41M |
|
-- |
|
$0.43M |
|
$6.84M |
|
$8.51M |
|
-- |
|
-- |
|
$8.51M |
|
$-1.67M |
|
$-1.67M |
|
$-1.67M |
|
0.60M |
|
| Cash Flow Statement Financials | |
$-9.07M |
|
-- |
|
$9.44M |
|
$5.79M |
|
$6.16M |
|
$0.37M |
|
|
Stock-Based Compensation |
$0.42M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.75 |
|
-- |
|
-- |
|
-- |
|
-3.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
312.48% |
|
312.48% |
|
-76.46% |
|
312.48% |
|
$-2.77 |
|
$-15.77 |
|
$-15.77 |
|